Advanced glycation end products measured by skin autofluorescence in a population with central obesity

Dermato-Endocrinology

Volumn 4, Issue 1, 2012, Pages 33-38

  Den Engelsen, Corine ^a   Van Den Donk, Maureen ^a   Gorter, Kees J ^a   Salomé, Philippe L ^b   Rutten, Guy E ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Huisartsenzorg IJsselstein ^*  (Netherlands)

Author keywords

Advanced glycation endproducts; Central obesity; Skin autofluorescence

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CREATININE;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; AUTOFLUORESCENCE; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; RISK FACTOR; SMOKING; WAIST CIRCUMFERENCE;

EID: 84861915718     PISSN: 19381972     EISSN: 19381980     Source Type: Journal    
DOI: 10.4161/derm.17999     Document Type: Article

References (28)

1. Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 2006; 114:597-605; PMID:16894049; http://dx.doi.org/10. 1161/CIRCULATIONAHA.106. 621854
2. Meerwaldt R, Graaff R, Oomen PH, Links TP, Jager JJ, Alderson NL, et al. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 2004; 47:1324-30; PMID:15243705; http://dx.doi.org/10.1007/s00125- 004-1451-2
3. Goh SY, Cooper ME. Clinical review: The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 2008; 93:1143-52; PMID:18182449; http://dx.doi. org/10.1210/jc.2007-1817
4. Smit AJ, Lutgers HL. The clinical relevance of advanced glycation endproducts (AGE) and recent developments in pharmaceutics to reduce AGE accumulation. Curr Med Chem 2004; 11:2767-84; PMID: 15544475
5. Gerrits EG, Lutgers HL, Kleefstra N, Graaff R, Groenier KH, Smit AJ, et al. Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications. Diabetes Care 2008; 31:517-21; PMID:18039805; http://dx.doi.org/ 10.2337/dc07-1755
6. Lutgers HL, Graaff R, Links TP, Ubink-Veltmaat LJ, Bilo HJ, Gans RO, et al. Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes. Diabetes Care 2006; 29:2654-9; PMID: 17130200; http://dx.doi.org/10.2337/dc05-2173
7. Meerwaldt R, Hartog JW, Graaff R, Huisman RJ, Links TP, den Hollander NC, et al. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. J Am Soc Nephrol 2005; 16: 3687-93; PMID:16280473; http://dx.doi.org/10.1681/ ASN.2005020144
8. Meerwaldt R, Lutgers HL, Links TP, Graaff R, Baynes JW, Gans RO, et al. Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care 2007; 30:107-12; PMID:17192342; http://dx.doi.org/ 10.2337/dc06-1391
9. Janiszewski PM, Janssen I, Ross R. Does waist circumference predict diabetes and cardiovascular disease beyond commonly evaluated cardiometabolic risk factors? Diabetes Care 2007; 30:3105-9; PMID: 17712026; http://dx.doi.org/10.2337/dc07-0945\
10. Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 2005; 81:555-63; PMID:15755822
11. Carey VJ, Walters EE, Colditz GA, Solomon CG, Willett WC, Rosner BA, et al. Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study. Am J Epidemiol 1997; 145:614-9; PMID:9098178
12. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114:1752-61; PMID:15599400
13. Silver AE, Beske SD, Christou DD, Donato AJ, Moreau KL, Eskurza I, et al. Overweight and obese humans demonstrate increased vascular endothelial NAD(P)H oxidase-p47(phox) expression and evidence of endothelial oxidative stress. Circulation 2007; 115:627-37; PMID:17242275; http://dx.doi.org/10. 1161/CIRCULATIONAHA.106.657486
14. Urakawa H, Katsuki A, Sumida Y, Gabazza EC, Murashima S, Morioka K, et al. Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab 2003; 88:4673-6; PMID: 14557439; http://dx.doi.org/10. 1210/jc.2003-030202
15. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 2003; 52:1-8; PMID:12502486; http://dx.doi.org/10. 2337/diabetes.52.1.1
16. Park K, Gross M, Lee DH, Holvoet P, Himes JH, Shikany JM, et al. Oxidative stress and insulin resistance: The CARDIA study. Diabetes Care 2009; 32:1302-7; PMID:19389821; http://dx.doi.org/10.2337/dc09-0259
17. Shah S, Iqbal M, Karam J, Salifu M, McFarlane SI. Oxidative stress, glucose metabolism, and the prevention of type 2 diabetes: pathophysiological insights. Antioxid Redox Signal 2007; 9:911-29; PMID: 17508914; http://dx.doi.org/10.1089/ars.2007.1629
18. Koetsier M, Lutgers HL. de JC, Links TP, Smit AJ, Graaff R. Reference values of skin autofluorescence. Diabetes Technol Ther 2010; 12:399-403; PMID: 20388050; http://dx.doi.org/10.1089/dia.2009.0113
19. Stirban A, Nandrean S, Negrean M, Koschinsky T, Tschoepe D. Skin autofluorescence increases postprandially in human subjects. Diabetes Technol Ther 2008; 10:200-5; PMID:18473694; http://dx.doi.org/10. 1089/dia.2007.0275
20. Imhof A, Woodward M, Doering A, Helbecque N, Loewel H, Amouyel P, et al. Overall alcohol intake, beer, wine, and systemic markers of inflammation in western Europe: results from three MONICA samples (Augsburg, Glasgow, Lille). Eur Heart J 2004; 25:2092- 100; PMID:15571824; http://dx.doi.org/10.1016/j.ehj. 2004.09.032
21. Teragawa H, Fukuda Y, Matsuda K, Higashi Y, Yamagata T, Matsuura H, et al. Effect of alcohol consumption on endothelial function in men with coronary artery disease. Atherosclerosis 2002; 165:145-52; PMID:12208480; http://dx.doi.org/10.1016/S0021-9150(02)00193-4
22. Monami M, Lamanna C, Gori F, Bartalucci F, Marchionni N, Mannucci E. Skin autofluorescence in type 2 diabetes: beyond blood glucose. Diabetes Res Clin Pract 2008; 79:56-60; PMID:17707942; http:// dx.doi.org/10.1016/j.diabres.2007. 07.007
23. Uribarri J, Cai W, Peppa M, Goodman S, Ferrucci L, Striker G, et al. Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J Gerontol A Biol Sci Med Sci 2007; 62:427-33; PMID: 17452738; http://dx.doi.org/10.1093/gerona/62.4.427
24. Hricik DE, Wu YC, Schulak A, Friedlander MA. Disparate changes in plasma and tissue pentosidine levels after kidney and kidney-pancreas transplantation. Clin Transplant 1996; 10:568-73; PMID:8996781
25. van den Donk M, Bobbink IWG, Gorter KJ, Salomé PL, Rutten GEHM. Identifying people with metabolic syndrome in primary care by screening with a mailed tape measure. A survey of 14,000 people in the Netherlands. Prev Med 2009; 48:345-50; PMID:19463483; http://dx. doi.org/10.1016/j.ypmed.2009.02.004
26. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection. Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-97; PMID:11368702; http://dx.doi.org/10.1001/jama.285.19.2486
27. Wendel-Vos GC, Schuit AJ, Saris WH, Kromhout D. Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity. J Clin Epidemiol 2003; 56:1163-9; PMID:14680666; http://dx.doi.org/ 10.1016/S0895-4356(03)00220-8
28. Stalman WAB, Scheltens T, Burgers JS, Hukkelhoven CWPM, Smorenburg SM, Banga JD, et al. NHG-Standaard Cardiovasculair risicomanagement. Houten: Bohn Stafleu van Loghum, 2006.